NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Swan NeuroTech

Swan NeuroTech

Private
Pittsburgh, PennsylvaniaHealthcare & Life Scienceshttps://swanneuro.com/

Last Round

Grant

May 28, 2024

Total Funding Raised

$20,000

Company Overview

Swan NeuroTech is a biotechnology company that develops biodegradable, biomaterial-based drug delivery implants designed to facilitate peripheral nerve repair and regeneration.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

nerve repairnerve guidenerve graftregenerative medicinenerve conduitbiomaterialdrug deliverybiodegradable implantperipheral nerve injurynerve regenerationmedical deviceneuro-regenerationbioengineeringbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Swan NeuroTech Comparables

Compare Swan NeuroTech with similar companies based on industry and business-model similarity.

Swan NeuroTech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Renerva, Inc.
90%
BioCircuit Technologies
87%
Neuraptive Therapeutics
78%
View all Comparables

Swan NeuroTech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 28, 2024
View all Funding Rounds

Swan NeuroTech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Swan NeuroTech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Swan NeuroTech's valuation, stock price, and market status.

Firmographic Details

HeadquartersPittsburgh, Pennsylvania
Employee Range3
Year Founded2019
Last FundingMay 28, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.